Detalhe da pesquisa
1.
Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq.
Breast Cancer Res Treat
; 186(3): 677-686, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33599863
2.
Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
J Biol Chem
; 294(27): 10530-10543, 2019 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126985
3.
PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
Mol Cell Biochem
; 470(1-2): 115-129, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415418
4.
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
Breast Cancer Res Treat
; 160(1): 29-40, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27613609
5.
Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
J Biol Chem
; 289(13): 9440-8, 2014 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24515104
6.
Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth.
Mol Cancer
; 11: 60, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22917272
7.
MUC1/A and MUC1/B splice variants differentially regulate inflammatory cytokine expression.
Exp Eye Res
; 93(5): 649-57, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854773
8.
PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs.
Cells
; 10(7)2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359849
9.
Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells.
Genes (Basel)
; 11(4)2020 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344635
10.
Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy.
Cancers (Basel)
; 11(5)2019 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100952
11.
Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors.
Melanoma Res
; 28(3): 250-255, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29561296
12.
Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
Oncotarget
; 5(16): 6670-86, 2014 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115398
13.
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
Cancer Metab
; 2(1): 2, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24451478
14.
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
Mol Cancer Ther
; 12(8): 1461-70, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23674815
15.
Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells.
Mol Cancer Ther
; 10(11): 2062-71, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21862684
16.
Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
Mol Cancer Ther
; 9(3): 594-605, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197399